Ruxolitinib in clinical practice for therapy of myelofibrosis: Single USA center experience following Food and Drug Administration approval

Holly Geyer, Keith Cannon, Emily Knight, Veena Fauble, John Camoriano, Robyn Emanuel, Raoul Tibes, Ruben Mesa

Research output: Contribution to journal › Letter › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Ruxolitinib in clinical practice for therapy of myelofibrosis: Single USA center experience following Food and Drug Administration approval'. Together they form a unique fingerprint.